1. Home
  2. LABT vs RAYA Comparison

LABT vs RAYA Comparison

Compare LABT & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$0.84

Market Cap

2.2M

Sector

Health Care

ML Signal

N/A

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

BUY

Current Price

$1.89

Market Cap

2.1M

ML Signal

BUY

Company Overview

Basic Information
Metric
LABT
RAYA
Founded
2006
2019
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.1M
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
LABT
RAYA
Price
$0.84
$1.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 638.8K
89.3K
Earning Date
11-18-2026
04-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$0.31
52 Week High
$6.85
$7.18

Technical Indicators

Market Signals
Indicator
LABT
RAYA
Relative Strength Index (RSI) 26.61 41.08
Support Level N/A $1.69
Resistance Level $2.13 $2.42
Average True Range (ATR) 0.21 0.24
MACD -0.10 0.01
Stochastic Oscillator 1.78 19.72

Price Performance

Historical Comparison
LABT
RAYA

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc is engaged in the manufacturing, research and development (R&D), and wholesale and retail of power solution products. The group focuses on manufacturing new energy storage and inverter devices. Its product portfolio includes sine wave and off-grid inverters, inverters and gasoline generators, battery and smart chargers, and custom-designed products. The products are used principally in agricultural and industrial vehicles, recreational vehicles (RVs), electrical appliances, and outdoor living products. The company generates the majority of its revenue from Inverters. The company generates revenue from five main markets, which are China, Poland, Mexico, the U.K., and Portugal. It derives maximum revenue from China.

Share on Social Networks: